JP2010511631A5 - - Google Patents

Download PDF

Info

Publication number
JP2010511631A5
JP2010511631A5 JP2009539526A JP2009539526A JP2010511631A5 JP 2010511631 A5 JP2010511631 A5 JP 2010511631A5 JP 2009539526 A JP2009539526 A JP 2009539526A JP 2009539526 A JP2009539526 A JP 2009539526A JP 2010511631 A5 JP2010511631 A5 JP 2010511631A5
Authority
JP
Japan
Prior art keywords
oxo
methyl
hydrazino
ylidene
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009539526A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010511631A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/086186 external-priority patent/WO2008070583A2/en
Publication of JP2010511631A publication Critical patent/JP2010511631A/ja
Publication of JP2010511631A5 publication Critical patent/JP2010511631A5/ja
Pending legal-status Critical Current

Links

JP2009539526A 2006-12-01 2007-11-30 トロンボポエチン擬態物 Pending JP2010511631A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86196306P 2006-12-01 2006-12-01
PCT/US2007/086186 WO2008070583A2 (en) 2006-12-01 2007-11-30 Thrombopoietin mimetics

Publications (2)

Publication Number Publication Date
JP2010511631A JP2010511631A (ja) 2010-04-15
JP2010511631A5 true JP2010511631A5 (enExample) 2011-01-27

Family

ID=39493014

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009539526A Pending JP2010511631A (ja) 2006-12-01 2007-11-30 トロンボポエチン擬態物

Country Status (6)

Country Link
US (2) US7786159B2 (enExample)
EP (1) EP2086551A4 (enExample)
JP (1) JP2010511631A (enExample)
AU (1) AU2007329464A1 (enExample)
CA (1) CA2670345A1 (enExample)
WO (1) WO2008070583A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY2010012I2 (el) * 2000-05-25 2020-05-29 Novartis Ag Μιμητικα θρομβοποιητινης
EP2086551A4 (en) * 2006-12-01 2011-06-08 Stategics Inc Thrombopoietin mimetics
US8476249B2 (en) 2009-05-07 2013-07-02 Glaxosmithkline Llc Method of treating thrombocytopenia
WO2010129738A1 (en) * 2009-05-07 2010-11-11 Glaxosmithkline Llc Method of treating thrombocytopenia
CN101921232A (zh) * 2009-06-11 2010-12-22 上海恒瑞医药有限公司 双环取代吡唑酮偶氮类衍生物的盐,其制备方法及其在医药上的应用
WO2012121958A2 (en) * 2011-03-08 2012-09-13 Glaxosmithkline Llc Combination
WO2013072921A2 (en) * 2011-09-13 2013-05-23 Glenmark Generics Limited Process for preparation of substituted 3'-hydrazino-biphenyl-3-carboxylic acid compounds
JP6072058B2 (ja) * 2011-11-14 2017-02-01 リガンド・ファーマシューティカルズ・インコーポレイテッド 顆粒球コロニー刺激因子受容体と結合する方法および組成物
JP6150374B2 (ja) * 2012-11-15 2017-06-21 国立大学法人弘前大学 放射線被ばく治療剤及び放射線被ばく治療方法
US9962370B2 (en) 2013-03-15 2018-05-08 Ligand Pharmaceuticals Incorporated Methods of treatment associated with the granulocyte colony-stimulating factor receptor
CN104257928A (zh) * 2014-10-20 2015-01-07 王艳萍 一种治疗软组织损伤疼痛综合症的中药制剂
KR102688415B1 (ko) 2017-07-26 2024-07-24 잔센파마슈티카엔.브이. 표적화된 방사선 치료요법에 의해 유도된 혈관 무결성을 보호하는 조성물
JP2022523663A (ja) * 2019-01-25 2022-04-26 ヤンセン ファーマシューティカ エヌ.ベー. 放射線処置および/または放射線模倣剤処置を伴う、肝損傷を緩和し、肝臓の肥厚、再生、および細胞の生着を促進するための方法
WO2024249284A2 (en) * 2023-05-26 2024-12-05 Ipsen Pharma S.A.S. Bax activators and use thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3141772A (en) * 1963-08-09 1964-07-21 Polaroid Corp Photographic products, processes and compositions employing azo dye developers
BE621310A (enExample) * 1961-08-10
DE1182432B (de) * 1962-04-26 1964-11-26 Basf Ag Verfahren zur Herstellung von thermoplastischen farbigen makromolekularen Stoffen
US3666746A (en) * 1969-06-25 1972-05-30 Gaf Corp Pyrrolidonylphenyl azo dyestuffs
US5132189A (en) * 1989-09-07 1992-07-21 Fuji Electric Co., Ltd. Photoconductor for electrophotography
JPH04128767A (ja) * 1990-09-19 1992-04-30 Fuji Electric Co Ltd 電子写真用感光体
EP1125990A4 (en) * 1999-07-29 2002-10-09 Mitsui Chemicals Inc YELLOW COMPOUND, AND WATER-CONTENT JET PRINTING INK COMPRISING THE COMPOUND
ES2256038T3 (es) * 1999-09-10 2006-07-16 Smithkline Beecham Corporation Mimeticos de trombopoyetina.
CY2010012I2 (el) * 2000-05-25 2020-05-29 Novartis Ag Μιμητικα θρομβοποιητινης
US7414040B2 (en) 2002-06-06 2008-08-19 Smithkline Beecham Corporation Thrombopoietin mimetics
WO2005118551A2 (en) 2004-05-28 2005-12-15 Ligand Pharmaceuticals Inc. Thrombopoietin activity modulating compounds and methods
CA2583764C (en) 2004-10-25 2009-06-09 Ligand Pharmaceuticals, Inc. Thrombopoietin activity modulating compounds and methods
US7226575B2 (en) * 2004-11-30 2007-06-05 Chevron U.S.A. Inc. Boron-containing molecular sieve CHA
BRPI0620532A2 (pt) * 2005-11-23 2011-11-16 Ligand Pharm Inc compostos e métodos para modular a atividade de trombopoietina
RU2008133161A (ru) 2006-01-13 2010-02-20 Фармасайкликс, Инк. (Us) Ингибиторы тирозин киназ и их применение
EP2086551A4 (en) 2006-12-01 2011-06-08 Stategics Inc Thrombopoietin mimetics

Similar Documents

Publication Publication Date Title
JP2010511631A5 (enExample)
JP2012533546A5 (enExample)
RU2434853C2 (ru) Новые конденсированные производные пиррола
JP2011524850A5 (enExample)
JP2010513478A5 (enExample)
CO6612204A2 (es) Nuevas composiciones de 1-(2(2.4 dimetil-fenilsulfanil)- fenil) piperazina
WO2007096151A3 (en) Inhibitors of p38-kinase for treatment of pulmonary hypertension
JP2010521514A5 (enExample)
JP2010077141A5 (enExample)
JP2007508360A5 (enExample)
JP2006514611A5 (enExample)
CN1878757A (zh) 吡啶酮衍生物及其应用
JP2010507641A5 (enExample)
JP2010526840A5 (enExample)
JP2008546770A5 (enExample)
JP2012507535A5 (enExample)
JP2006501306A5 (enExample)
WO2009055721A3 (en) 5-lipoxygenase activating protein (flap) inhibitor
CY1112911T1 (el) Θεραπευτικος παραγοντας ηπατικης νοσου, που περιεχει παραγωγο 2-αμινο-1,3-προπανοδιολης ως δραστικο συστατικο
JP2007532607A5 (enExample)
JP2008534558A5 (enExample)
JP2010501017A5 (enExample)
JP2009040767A5 (enExample)
JP2012501334A5 (enExample)
JP2010500284A5 (enExample)